MesotheliomaDR logo

24/7 Patient Assistance: 760-405-8205

Joshua Menke, MD

Pathologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Clubbed Fingers Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma

Hospitals & Clinics

UCSF Medical Center

specialties & services

Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel

  • Bio & Insurance Information

    Dr. Joshua Menke is a specialist in pathology from San Francisco, California. He graduated from the University of Florida College of Medicine. He received the Paul E. Strandjord Young Investigator Award for his activity. Dr. Menke contributed to two published studies that focused on TMEM106B risk variants and the Alzheimer disease and periventricular white matter immunoglobulin lambda light chain deposition. At the moment, Dr. Joshua Menke is affiliated with the UCSF Medical Center.

    Insurance Accepted

    Aetna

  • Education & Training

    dept_icon

    University of Florida College of Medicine

    Medical School

  • Board Certifications

    American Board of Pathology

  • Hospital & Practice

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Joshua Menke has contributed to 2 publications.

    TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease.

    Rutherford NJ Carrasquillo MM Li M Bisceglio G Menke J Josephs KA Parisi JE Petersen RC Graff-Radford NR Younkin SG Dickson DW Rademakers R; Neurology. 2012 Aug 14 .

    See more >>

    Periventricular white matter immunoglobulin lambda light chain deposition disease diagnosed by proteomic analysis.

    Menke JR Jentoft ME Dogan A Avent JM Miller DV Giannini C; Acta Neuropathol. 2012 Aug .

    See more >>